Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.11.5525

Standardized Breast Cancer Mortality Rate Compared to the General Female Population of Iran  

Haghighat, S. (Epidemiology Department, School of Public Health, Shahid Beheshti University of Medical Sciences (SBMU))
Akbari, M.E. (Cancer Research Center (CRC))
Ghaffari, S. (Iranian Social Security Organization)
Yavari, P. (Epidemiology Department, School of Public Health, Shahid Beheshti University of Medical Sciences (SBMU))
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.11, 2012 , pp. 5525-5528 More about this Journal
Abstract
Introduction: Breast cancer is the most common cancer in women. Improvements of early diagnosis modalities have led to longer survival rates. This study aimed to determine the 5, 10 and 15 year mortality rates of breast cancer patients compared to the normal female population. Materials and Methods: The follow up data of a cohort of 615 breast cancer patients referred to Iranian Breast Cancer Research Center (BCRC) from 1986 to 1996 was considered as reference breast cancer dataset. The dataset was divided into 5 year age groups and the 5, 10 and 15 year probability of death for each group was estimated. The annual mortality rate of Iranian women was obtained from the Death Registry system. Standardized mortality ratios (SMRs) of breast cancer patients were calculated using the ratio of the mortality rate in breast cancer patients over the general female population. Results: The mean age of breast cancer patients at diagnosis time was 45.9 (${\pm}10.5$) years ranging from 24-74. A total of 73, 32 and 2 deaths were recorded at 5, 10 and 15 years, respectively, after diagnosis. The SMRs for breast cancer patients at 5, 10 and 15 year intervals after diagnosis were 6.74 (95% CI, 5.5-8.2), 6.55 (95%CI, 5-8.1) and 1.26 (95%CI, 0.65-2.9), respectively. Conclusion: Results showed that the observed mortality rate of breast cancer patients after 15 years from diagnosis was very similar to expected rates in general female population. This finding would be useful for clinicians and health policy makers to adopt a beneficial strategy to improve breast cancer survival. Further follow-up time with larger sample size and a pooled analysis of survival rates of different centres may shed more light on mortality patterns of breast cancer.
Keywords
Breast Cancer; SMR; survival; mortality rate; Iran;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Akbari ME, Khayamzadeh M, Khoshnevis S, et al (2008). Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience. Iranian J Cancer Prev, 1, 53-7.
2 Cabanes A, Vidal E, Perez-Gomez B, et al. (2009). Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol, 33, 169-75.   DOI   ScienceOn
3 Cancer Office MOH (2009). Iranian Annual Report of Cancer Registration 2007-2008, Cancer Office CDC, Deputy for Health. Ministry of Hlth and Medical Educ of Iran
4 Chen HH, Thurfjell E, Duffy SW, Tabar L (1998). Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. J Epidemiol Community Hlth, 52, 329-35.   DOI
5 Christopher IL (2010). Breast Cancer Epidemiology. New York Springer.
6 Death Office MOH (2007). Iranian Annual Report of Death Registration 2006 Deputy for Health, Ministry of Health and Medical Educ of Iran.
7 Demicheli R, Ardoino I, Boracchi P, et al. (2010). Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer, 10, 656.   DOI
8 Erbas B, Hyndman RJ, G DM (2007). Forecasting age-specific breast cancer mortality using functional data models. Stat Med, 26, 458-70.   DOI   ScienceOn
9 Finkelstein DM, Muzikansky A and Schoenfeld DA (2003). Comparing survival of a sample to that of a standard population. J Natl Cancer Inst, 95, 1434-9.   DOI
10 Hirte L, Nolte E, Bain C, McKee M (2007). Breast cancer mortality in Russia and Ukraine 1963-2002: an age-periodcohort analysis. Int J Epidemiol, 36, 900-6.   DOI
11 Jatoi I, Chen BE, Anderson, Rosenberg PS (2007). Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol, 25, 1683-90.   DOI
12 Johnson ES, Faramawi MF, Sall M, Choi KM (2011). Cancer and noncancer mortality among American seafood workers. J Epidemiol, 21, 204-10.   DOI
13 Khadivi R, Harrirchi I, Khosravi Z, Akbari ME (2008). Ten year breast cancer screening and follow up in 52200 women in Shahre-Kord, Iran (1997-2006). Iranian J Cancer Prev, 1, 73-6.
14 Mousavi Naiini M, Mofid B, Mohebi H, et al (2009). "Comparison the effect of two methods of surgery in breast cancer recurrence, Metastasis and survival. Kosar Medical J, 14, 89-94.
15 Mousavi S, Montazeri A, Mohaghegh M, et al (2007). Breast cancer in iran: an epidemiological review. Breast J, 13, 383-391.   DOI
16 Movahedi M, Haghighat SH, Khayamzadeh M, et al (2011). Survival rate of breast cancer based on geographical variaation in Iran, a national study." RCJ (in press).
17 Tabar L, Fagerberg G, Day NE, et al (1992). Natural history of breast cancer. Lancet, 339, 1108.
18 Yavari p, Abadi A and Mehrabi Y (2003). Mortality and changing epidemiological trends in Iran during 1979-2001. Hakim, 6, 8-14.
19 Will BP, Berthelot JM, Le Petit C, et al. (2000). Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer, 36, 724-35.   DOI
20 Yaghmaii S, Banihashemi G, Ghorbani R (2007). Breast cancer Survavial and correlated factors in Emdad Hospital of Semnan. Semnan Medical Univ J, 9(2).
21 Zahl PH, Maehlen J (2005). Reduction in mortality from breast cancer: decrease with screening was marked in younger age group. BMJ, 330, 1024 author reply 1025.